Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $40.0000 (0.76%) ($39.3900 - $40.7000) on Wed. Sep. 19, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.05% (three month average) | RSI | 51 | Latest Price | $40.0000(0.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -0.1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.525% in a week (0% probabilities). VXX(-15%) VIXM(-14%) TLT(-14%) UUP(-12%) IFRA(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.525% (StdDev 3.05%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $40.13(-0.32%) | 10 Day Moving Average | $40(0%) | 20 Day Moving Average | $39.78(0.55%) | To recent high | -14.7% | To recent low | 14.1% | Market Cap | $2.972b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |